Detalles de la búsqueda
1.
Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages.
Nature
; 543(7645): 428-432, 2017 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-28273064
2.
Immunomodulation of NK, NKT and B/T cell subtypes in relapsed/refractory multiple myeloma patients treated with pomalidomide along with velcade and dexamethasone and its association with improved progression-free survival.
Front Oncol
; 13: 1271807, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38111533
3.
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer.
Cancer Res
; 81(1): 158-173, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33158814
4.
Development of an 8-color antibody panel for functional phenotyping of human CD8+ cytotoxic T cells from peripheral blood mononuclear cells.
Cytotechnology
; 70(1): 1-11, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28551826
5.
PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer.
Cell Rep
; 25(11): 2972-2980.e5, 2018 12 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30540933
6.
Characterization of midostaurin as a dual inhibitor of FLT3 and SYK and potentiation of FLT3 inhibition against FLT3-ITD-driven leukemia harboring activated SYK kinase.
Oncotarget
; 8(32): 52026-52044, 2017 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28881711
7.
Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors.
Science
; 356(6335)2017 04 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28428369
Resultados
1 -
7
de 7
1
Próxima >
>>